Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension

J Cardiovasc Pharmacol. 1992:19 Suppl 5:S128-33.

Abstract

The effects of converting enzyme inhibition on coronary and systemic hemodynamics in the presence of a chronically activated renin-angiotensin system were investigated in five renovascular hypertensive patients with no ECG/echocardiographic evidence of left ventricular hypertrophy. Coronary blood flow (CBF, thermodilution technique), intra-arterial blood pressure, AVO2 difference (coronary sinus), heart rate, and coronary vascular resistance were measured at rest, during isometric exercise (handgrip to 50% of maximal effort for 3 min) before and 60 min after 2.5 mg of oral cilazapril. The drug induced a prompt, significant decrease in mean arterial pressure and a sustained increase in CBF. The performance of handgrip after cilazapril resulted in higher increases in CBF for a given increase in myocardial oxygen requirements. These observations suggest that angiotensin II (Ang II) maintains the ability to alter the control mechanisms of CBF even under long-term conditions and that converting enzyme inhibition reverses the Ang II-induced effects on coronary hemodynamics.

MeSH terms

  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Blood Pressure / drug effects
  • Cilazapril
  • Coronary Circulation / drug effects*
  • Hemodynamics / drug effects*
  • Humans
  • Hypertension, Renovascular / drug therapy*
  • Hypertension, Renovascular / physiopathology
  • Middle Aged
  • Oxygen Consumption / drug effects
  • Physical Exertion / physiology
  • Pyridazines / pharmacology*
  • Pyridazines / therapeutic use
  • Vascular Resistance / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Pyridazines
  • Cilazapril